As Chief Clinical Officer at Mend, I’m implementing measurement-based care across hundreds of practices. Here’s what the research shows about this simple but powerful change.
Here’s the stat that stops every conversation: 74% remission rate with measurement-based care vs. 29% without it.¹
That’s not a typo. When practices use tools like the PHQ-9 and GAD-7 for routine monitoring, nearly three-quarters of patients achieve remission compared to less than one-third with standard care alone.
But what really gets me? Average time to remission: 6 weeks.² Six weeks. Not six months—six weeks.
Half the battle is knowing what you’re measuring. The research gives us clear targets:
Research from the Norwegian PMHC program shows that using these thresholds led to 45% recovery rates maintained at 12-month follow-up, demonstrating the long-term value of clear measurement targets.¹
Let me tackle the biggest objection I hear: “This is just more paperwork.”
Reality check from actual implementation data:
But here’s the real game-changer: when you automate the process, it’s even simpler. At Mend, we’ve automated PHQ-9 and GAD-7 assessments so patients complete them before sessions without staff involvement. The data flows directly into your EHR, alerts trigger for high-risk scores, and you walk into the session already knowing exactly where your patient stands.
That’s not an administrative burden—that’s clinical efficiency. When your patient’s anxiety scores plateau at week 4, you don’t wait until week 8 to adjust treatment. You act immediately.
Here’s what surprised me most: patients don’t just tolerate symptom tracking, they ask for it. Research shows patients value seeing their scores improve over time because it “increased awareness of improvement and reduced anxiety.”⁸
Think about it. Mental health feels subjective. When someone sees their PHQ-9 drop from 18 to 10 over six sessions, that’s concrete proof their investment in therapy is paying off.
The difference between 29% and 74% remission isn’t just statistics. This is real people getting their lives back faster.
After implementing MBC across hundreds of practices, I can say this isn’t just another clinical tool. It’s a practice transformation. The question isn’t whether you can afford to implement measurement-based care.
It’s whether you can afford not to.
Dr. Elise Herman is Chief Clinical Officer at Mend, where she leads clinical strategy for mental and behavioral healthcare organizations.
If you’re ready to see how measurement-based care can drive better outcomes without adding more work to your team’s plate, let’s talk. Mend’s fully automated MBC solution integrates seamlessly into your existing workflows—no portal logins, no manual data entry, just the insights you need when you need them. Schedule a demo and see how Mend can help you deliver faster remission, smarter decisions, and more confident care.
